However, there is no evidence about the redox status and the possible role of microbiome in these models, and further data are needed to better understand the possible implications of an altered homeostasis of microbiome in HMGB1-dependent arthritis and in anti-HMGB1 therapy efficacy. The gene discussed is HMGB1; the disease is arthritic joint disease.